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Abstract  
 
In our analysis of a QTL for plasma TG levels (LOD=3.6) on human chromosome 7q36, 
we examined 29 single nucleotide polymorphisms (SNPs) across INSIG1, a biological 
candidate gene in the region. Insulin-induced genes (INSIGs) are feedback mediators of 
cholesterol and fatty acid synthesis in animals, but their role in human lipid regulation is 
unclear.  
In our cohort, the INSIG1 promoter SNP rs2721 was associated with TG levels  
(p=2 x 10-3 in 1,560 individuals of the original linkage cohort, p=8 x 10-4 in 920 unrelated 
individuals of the replication cohort, combined p=9.9 x 10-6). Individuals homozygous 
for the T allele had 9% higher TG levels, and two-fold lower expression of INSIG1 in 
surgical liver biopsy samples when compared to individuals homozygous for the G allele. 
Also, the T allele showed additional binding of nuclear proteins from HepG2 liver cells 
in gel shift assays. Finally, the variant rs7566605 in INSIG2, the only homologue of 
INSIG1, enhances the effect of rs2721 (p= 0.00117). The variant rs2721 alone explains 
5.4% of the observed linkage in our cohort, suggesting that additional so far undiscovered 
genes and sequence variants in the QTL interval also contribute to alterations in TG 
levels in humans.   
 
Key words:  triglyceride, INSIG2, SNP association, gene expression, EMSA 
 by guest, on Novem
ber 3, 2010
w
w
w
.jlr.org
D
ow
nloaded from
 
Introduction 
 
Increased plasma triglyceride (TG) levels are an important cardiovascular risk factor, and 
are strongly associated with atherosclerotic heart disease (1,2). Plasma TG levels vary 
widely between individuals, and both genetic and environmental factors have been shown 
to contribute to elevated plasma TG concentrations (3-7). Elevated plasma TG levels are 
often observed in obese and diabetic individuals and in individuals affected by the 
metabolic syndrome, a common chronic disorder associated with obesity, insulin 
resistance, hypertension, and alterations in plasma lipid profile such as elevated serum 
triglycerides and low HDL levels. This characteristic pattern is similar to lipid 
abnormalities reported in familial combined hyperlipidemia (8).  
The Metabolic Risk Complications of Obesity Genes (MRC-OB) project was 
established in 1994 to identify the genetic determinants of the metabolic syndrome and its 
metabolic abnormalities (9). As part of the project, 2,209 individuals from 507 families 
were ascertained for basic anthropomorphic phenotypes, plasma lipid measures, and 
fasting glucose and insulin levels. A genome-wide linkage scan of these families 
identified a quantitative trait locus (QTL) on human chromosome 7q36 linked to plasma 
triglyceride levels (LOD=3.7) (10). This region has also been implicated in numerous 
other studies (11-15), and represents one of the most replicated linkages for dyslipidemia 
and elevated TG levels. The genomic interval on chromosome 7q36 includes 22 known 
genes, including insulin-induced gene 1 (INSIG1), the only biological candidate. 
INSIG1 was initially described as an insulin-induced transcript, designated CL-6 
(16). It was later re-named INSIG1 following cloning and assignment to chromosome 
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7q36 (17). INSIG1 has been shown to affect the feedback regulation of cellular 
cholesterol (18, 19). Sterol regulatory element binding proteins (SREBPs), which are 
transcription factors located in the endoplasmic reticulum, control the synthesis of 
cholesterol and fatty acids. When cellular cholesterol levels fall, SREBPs bind to SREBP 
cleavage-activating proteins (SCAPs) in order to be transported to the Golgi, where they 
undergo proteolytic cleavage (20). The NH2-terminal fragment translocates to the nucleus 
to activate the transcription of target genes including INSIG1 (21) that are involved in the 
synthesis of cholesterol and fatty acids. As cellular sterol levels rise, SCAP binds to 
INSIG1, thus preventing the transport of the SCAP/SREBP complex to the Golgi (18) and 
halting the synthesis of cholesterol and fatty acids (for detailed reviews, see (22, 23)). 
INSIG1 and its only mammalian homologue INSIG2 may also exert their feedback 
regulators of cholesterol synthesis by directly binding to 3-Hydroxy-3-methylglutaryl 
coenzyme A (HMG CoA) reductase, which triggers sterol-accelerated ubiquitination and 
degradation of HMG CoA reductase, the rate-limiting enzyme of cholesterologenesis (for 
a detailed review, see (24)).   
Over-expression of INSIG1 has been shown to reduce high levels of TG in both 
liver and plasma of Zucker diabetic fatty rats (25). It has been proposed that this effect is 
due to the mechanism outlined above (18). In addition, single knockout of either INSIG1 
INSIG2 in mice leads to increased total content of both cholesterol and TG in mouse 
livers, an effect exacerbated significantly when both INSIG genes are knocked out (26). 
These studies indicate that INSIG1 and INSIG2 interactively contribute to the control and 
regulation of lipid homeostasis in animals.  
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Based on this evidence, we hypothesized that sequence variation in INSIG1, 
which is located in the QTL region on human chromosome 7q36 linked to plasma TG 
levels, contributes to the observed genetic effect on plasma lipid levels. Here we present 
data on our comprehensive association analysis of sequence variants in INSIG1 in the 
initial MRC-OB cohort and a second replication cohort of unrelated individuals, and 
evidence for a synergistic effect of an associated sequence variant in INSIG1 with a 
variant in INSIG2 on plasma TG levels. Furthermore, our data suggest that a putative 
causal promoter variant in INSIG1 affects gene expression of INSIG1 in liver tissue, 
potentially by altering the binding of nuclear factors to the promoter sequence. 
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Methods 
 
Study Design  
We performed a family-based study on genetic contributions to plasma triglyceride 
levels.  
Study cohort  
Cohort recruitment and individual phenotyping have been described in detail previously 
(9,10). In brief, families with at least two obese siblings [body mass index (BMI) >30], 
the availability of at least one parent, and one or more never obese siblings (BMI <27) 
were recruited from the TOPS (Take Off Pounds Sensibly, Inc.) membership in ten 
Midwestern U.S. states. Health information of all participants was obtained by a 
questionnaire. Individuals were excluded from recruitment with the following conditions: 
pregnancy, type 1 diabetes, history of cancer, renal or hepatic disease, severe coronary 
artery disease, substance abuse, corticosteroids or thyroid dosages above replacement 
dose, history of weight loss of more than 10% in the preceding 12 months, as well as 
individuals receiving lipid-lowering medications. Phenotypic measurements included 
height, weight, waist and hip circumferences, and fasting plasma levels of glucose, 
insulin, total cholesterol, LDL-cholesterol, HDL-cholesterol, and TG. A total of 2,209 
individuals distributed over 507 families of Northern European descent qualified for the 
above-mentioned criteria and thus formed the initial study population, of which 1,560 
individuals from 261 families that contributed to the linkage on chromosome 7q36 
(family LOD >0) were selected for further studies reported here.  
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Confirmatory studies were performed from a cohort of unrelated individuals of 
Northern European descent recruited by the same criteria from the same geographic 
regions. Samples from 920 unrelated individuals were available for this study. All 
protocols were approved by the Institutional Review Board of the Medical College of 
Wisconsin, and all participants signed an informed consent. Details on the two cohorts 
used in this study are included in Table 1.  
 
Measurements 
Genotyping 
SNPs were genotyped using Invader technology as described for previous studies (27-
30). Genotyping was carried out in a total volume of 6µl, containing 0.5µl of PCR 
product, 0.02µl of each primary probe, 0.002µl of Invader probe, 1.12µl of 2.6M betaine 
(Sigma, St.Louis, MO), 2.75µl TE buffer, 0.35µl Cleavase (TWT) and 1.24µl FRET mix 
(TWT). Reactions were denatured at 95°C for five minutes and then heated at 63°C for 
15-120 min. Additional SNPs were genotyped on an Affymetrix MegAllele custom-
designed 3K array using molecular inversion probe technology, as described previously 
(28). The location of all SNPs included in the analysis is shown in Figure 1. 
 
Sequencing and SNP identification 
A 4,139 bp region was re-sequenced in 47 unrelated individuals selected from the MRC-
OB cohort. The region was amplified by PCR using 21 overlapping amplicons 261 to 444 
bp in size. PCR products were purified using MultiScreen-FB plates (Millipore); and 
eluted in sterile H2O for sequencing. Sequencing was carried out using BigDye v.3.1 
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chemistry (Applied Biosystems, CA, USA) with standard techniques and analyzed on an 
Applied Biosystems 3730xl DNA Analyzer. SNP loci were identified by aligning all 
sequences using POLYPHRED (31), all putative sites were checked manually for 
confirmation. Results were independently confirmed by aligning all traces with the 
chromosome 7 reference sequence using the anchored alignment algorithm in 
POLYBAYES(32) and using POLYPHRED to screen for SNPs.  
 
Expression profiling 
RNA isolation, anti-sense RNA generation and Illumina BeadChip hybridization of the 
liver samples as well as transcript detection and normalization were performed as 
previously described (33). Briefly, a liver biopsy was obtained from each of 73 morbidly 
obese subjects of Northern European descent undergoing bariatric surgery. RNA was 
extracted and analyzed using Illumina Human-6 Expression BeadChips which allow 
interrogation of almost 48,000 transcripts. Gene expression data for all liver samples 
were analyzed according to Goring et al. (33). To identify transcripts with detectable 
quantitative expression in the samples, distribution of expression values for a given 
transcript were compared to those of the controls imbedded in each chip. All significantly 
expressed transcripts were identified using an FDR of 0.05. To minimize the influence of 
overall signal levels, which may reflect RNA quantity and quality rather than a true 
biological difference between individuals, abundance values of all transcripts were 
standardized by z-scoring within individuals (using decile percentage bins of transcripts, 
grouped by average log transformed raw signals across individuals), followed by linear 
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regression against the individual-specific average log-transformed raw signal and its 
squared value, as discussed by Goring et al. (33). 
For the analysis of allele-specific expression differences in INSIG1, individuals 
were grouped according to genotype (for rs2721), and their gene-specific normalized 
expression z-scores were compared for genotype-specific differences using ANOVA. 
Differences between individual genotypes were compared using t-tests.  
 
Electrophoretic Mobility Shift Assay (EMSA) 
The human HepG2 cell line was maintained in DMEM, supplemented with 2 mM L-
glutamine, 100 mg/ml each of streptomycin and penicillin, and 15% fetal bovine serum, 
at 37°C with 5% CO2. Complementary oligonucleotides representing both allelic forms of 
the INSIG1 promoter SNP (rs2721, G>T at -2253 to the start codon) were obtained 
commercially (Integrated DNA Technologies) and purified by high performance liquid 
chromatography (HPLC). EMSA was performed as described previously (34). Briefly, 
nuclear extracts were prepared from approximately 8×107 cells. Extracts were frozen in 
liquid N2 and stored at -80°C. For EMSA, nuclear proteins (3µg) were pre-incubated for 
10 min on ice with 1µg of poly (dI-dC) (Pharmacia) in a binding buffer (4% Ficoll, 
20mM HEPES [pH 7.9], 1mM EDTA, 1 mM DTT, 50 mM KCl ). Nuclear proteins were 
then incubated with biotin-labeled double-stranded oligonucleotide probes (20 fmol) for 
30 min on ice and then analyzed on a 6% Novex® DNA retardation gels (Invitrogen, CA, 
USA), and electroblotted onto a positively charged nylon membrane (Ambion, Austin, 
TX). Detection of protein/DNA complexes was achieved following incubation of the 
membrane with strepavidin-horseradish peroxidase and development with luminal 
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substrate (Lightshift Chemiluminescent EMSA kit; Pierce, IL, USA). Light emission was 
captured on X-ray film.  
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Statistical Analysis 
 
Initial association analysis discovered rs2721  
As triglyceride levels are continuously distributed, the data were first examined for 
deviations from normality. Raw triglyceride levels exhibited an increased number of high 
values, so the data were natural log (ln) transformed. Data were re-examined and 
observations exceeding 4 standard deviation units were removed as outliers. In all 
models, triglycerides were adjusted for age, sex, age by sex, age squared, age squared by 
sex, and type 2 diabetes status. 
To test for statistical association with SNPs in INSIG1, we identified 11 tagSNPs 
in the INSIG1 gene region (~40 kb) from the Hapmap database using the tagger function 
in Haploview with default settings (35,36). After sequencing the promoter and the first 
exon of INSIG1 in 47 unrelated individuals, we identified an additional 17 SNPs. All 28 
SNPs were genotyped in the full cohort (n = 1560) and were tested for association with 
ln(triglycerides). 
For each SNP, we used the measured genotype approach to test for association. 
Briefly, in this approach the effects of the individual SNP genotypes will be modeled by 
assigning genotypic values such that the homozygotes will be assigned values of 1 and –1 
and the heterozygotes will be assigned 0, providing an additive model (37). To account 
for the phenotypic correlation between family members, we used variance components 
analysis with the SNPs screened individually as covariates in the computer program 
SOLAR (Sequential Oligogenic Linkage Analysis Routines) (38).  
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Confirmatory association analysis in unrelated individuals 
To confirm associations identified in the family-based analyses, we genotyped SNP 
rs2721 in a cohort of 920 unrelated individuals. Genotypes were coded as described 
above and were considered the independent variable. Triglycerides were ln transformed 
to improve normality of the distribution. As this was an unrelated cohort, we performed 
linear regression analysis using SAS v9.1 (SAS, Carey NC).  
 
Meta-Analysis of both cohorts 
To assess the combined effect of rs2721 in both cohorts, we combined the p-values using 
the Z-transformation. This approach is detailed by Whitlock et al. (39) and implemented 
in the Util program (http://www.genemapping.cn/util.htm). 
 
Interaction analysis with INSIG2 
To determine whether there was an interaction between INSIG1 and INSIG2, as 
suggested from mouse knockout studies, we first examined the relationship between the 
family specific LOD scores for triglycerides at the two loci (40). Second, we genotyped 
two SNPs in INSIG2 (rs57566605 and rs2422166) that had been reported to be associated 
with BMI and LDL-C in other studies (41-43), and tested for both main effects and 
interaction effects using the measured genotype analysis in SOLAR. Third, we examined 
the impact of INSIG1 variants conditional on INSIG2 variants. These analyses were 
performed by subsetting the data by INSIG2 genotype and then performing measured 
genotype analysis for the effect of INSIG1 genotype. 
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Results 
 
Association of INSIG1 sequence variants with TG in the MRC-OB cohort 
The QTL on chromosome 7q35-q36 linked to plasma TG levels has been replicated in 
multiple cohorts (10-15). Among the 22 identified genes in this QTL, INSIG1 is the only 
candidate with known biological roles that are related to lipid metabolism and therefore 
has been the focus of this study.  
Initially, we tested for INSIG1 association using 11 SNPs selected from the 
Hapmap database using the tagger function of Haploview (35, 36) (Figure 1 and Table 2). 
These SNPs spanned the entire INSIG1 gene region (39.7 kb). One variant in the putative 
promoter region of INSIG1, rs2721, was significantly associated with plasma triglyceride 
levels in 1,560 individuals from our cohort (p=0.002). Two additional SNPs (rs9770068 
and rs9769506) located in intron 6 of INSIG1, showed marginal association (p=0.047 and 
p=0.037, respectively), as well as one additional SNP in the promoter region (rs9690040, 
p=0.045). As these three marginally associated SNPs are in almost complete linkage 
disequilibrium with rs2721 (Fig.1), we speculate that their high degree of correlation may 
have led to the observed associations.  
The promoter variant (rs2721) is located 2253 bp upstream of the transcription 
start site of INSIG1. In order to include all other variants surrounding rs2721 in the 
association analysis, we re-sequenced the promoter region and exon 1 in 47 unrelated 
individuals from our cohort. SNPs in the remaining exons of the gene were in high LD 
with each other, and not in LD with rs2721, thus, we focused solely on the region 
surrounding rs2721. All selected individuals were parents from families contributing 
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significantly to the initially observed linkage on chromosome7 in the MRC-OB cohort. 
The re-sequencing effort uncovered 17 additional SNPs, of which 8 were novel and not 
reported in dbSNP. The location of all SNPs is shown in Figure 1.  
All 28 SNPs were genotyped in the 1,560 individuals from the MRC-OB cohort. 
The results of the association analysis are summarized in Table 2. No additional SNPs 
were associated with plasma triglyceride levels in this cohort, suggesting that the effect is 
primarily mediated by rs2721. The TG levels of individuals homozygous for the G allele 
(123.1±2.3 mg/dl, n=1073) were on average 9% lower than those of individuals 
homozygous for the T allele (135.9±16.2 mg/dl, n=31).  
 
Next, we examined the effect of the SNP on the initial linkage. Overall, the QTL 
interval on chromosome 7q36 explains 31% of the variance in TG levels in our cohort. 
When including SNP rs2721 in INSIG1 as a covariate, the linkage drops 5.4% for our 
family-based cohort, suggesting a modest but significant effect on the initial linkage on 
chromosome 7q36 that explains 1.6% of the total observed variance in TG levels in the 
study cohort.  
 
Replication of association analysis 
To validate the association seen in the family-based MRC-OB cohort, we examined the 
effect of the associated variant rs2721 in a second study cohort. The details of the cohort 
are summarized in Table 1. 920 individuals were genotyped and included in the analysis. 
The minor allele frequency (MAF) of rs2721 in this cohort is comparable to the MAF of 
rs2721 in the initial family-based cohort (15.1% vs. 14.5%). Again, rs2721 is strongly 
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associated with plasma triglyceride levels (p=8×10-4), confirming the finding in our 
initial family-based cohort. In this replication cohort, individuals homozygous for the T 
allele of rs2721 (n=21) had mean TG levels of 150.3±18.8 mg/dl, compared to 135.9±2.9 
mg/dl for individuals homozygous for the G allele (n=674).  
When both datasets are combined using a Z-transformation (39), rs2721 is 
associated with altered TG levels with a p-value of 9.9 x 10-6. 
 
Functional analysis of rs2721 
To assess whether rs2721 may have a direct functional effect, we examined whether the 
sequence variant is correlated with INSIG1 expression levels since the SNP is located in 
the promoter region of the gene. We examined mRNA expression levels of INSIG1 in 73 
liver biopsy samples from morbidly obese patients (BMI>36). All individuals were 
genotyped for rs2721, and average gene expression levels were compared within different 
genotype groups. The T allele reduced INSIG1 gene expression levels significantly. In 
liver, individuals with TT genotype (n=2) had 2-fold lower levels of INSIG1 mRNA 
when compared to those with TG (n=23, p=0.046) or GG types (n=48, p=0.030) (mean z-
score difference of 0.52, p=0.02). INSIG1 expression in heterozygous individuals was not 
significantly different from GG homozygous individuals (p=0.40).  
 
Based on this observed correlation between INSIG1 gene expression and rs2721 
genotype, we investigated whether the two alleles may have differential affinities to 
nuclear proteins such as transcription factors, which may change the transcription levels 
that eventually lead to the altered lipid profiles. We performed electrophoretic mobility 
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shift assays (EMSA) using biotin-labeled double-stranded DNA (41 bp) surrounding SNP 
rs2721 (20 nucleotides both upstream and downstream). As shown in Figure 2, the 
presence of the T allele in the promoter DNA leads to a shift in observed bands after 
binding of nuclear extracts from HepG2 cells when compared to the G allele. This shift is 
not seen in control experiments without nuclear extract or biotinylated probes. These 
results show that the two alleles of rs2721 have different affinities to nuclear proteins. 
While the protein(s) binding to the sequence surrounding rs2721 are currently unknown, 
it is possible that this differential binding mediates the observed difference in INSIG1 
gene expression, and thereby affects plasma TG levels in individuals homozygous for the 
T allele.  
 
Interaction between INSIG1 and INSIG2 
In humans, the INSIG1 protein is 78% similar to its only homologue INSIG2. 
Interestingly, while INSIG1 is involved in the feedback regulation of lipid synthesis, 
INSIG2 has been shown to be associated with obesity and adipocyte metabolism in a 
number of recent studies(41-43). However, no study to date has addressed whether these 
two genes work cooperatively in humans to affect lipid levels, as has been shown in mice 
(26).  
 
Correlation analysis based on family-specific LOD scores of the locus of INSIG1 
and the locus of INSIG2 suggested a non-additive interaction between the two genes  
(ρ=-0.239, p<0.0001). Based on these results, we selected two SNPs in INSIG2 
(rs2422166 and rs7566605) that have been repeatedly shown to be associated with BMI 
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and LDL-C in other studies (41-43). Gene-gene interaction analysis was performed on 
the two INSIG2 SNPs and rs2721 of INSIG1. In this analysis, SNP rs2422166 did not 
show any effect on TG levels directly or through interaction with rs2721. In contrast, 
SNP rs7566605 showed marginal interaction with rs2721 (p=0.0473) although it was not 
directly associated with TG levels. To measure the impact of genotype at rs7566605 on 
the association of rs2721 with lipid traits, we grouped the data based on genotype at 
rs7566605. Measured genotype analysis was then performed in these subsets (Table 3). In 
the GG subgroup, the associations with TG levels disappeared. In contrast, in the CC-CG 
subgroup, the association was significantly strengthened (β=0.13±0.04, p=0.00117). 
Here, individuals homozygous for the T allele of rs2721 had 31% higher TG levels than 
individuals homozygous for the G allele (138.4±1.9 mg/dl vs. 105.6±1.7 mg/dl). Before 
we stratified the study cohort based on genotypes of INSIG2 rs7566605, the difference 
between the INSIG1 rs2721 homozygous groups was only 8%. 
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Discussion 
 
Studies conducted in animals have revealed intriguing and critical roles of INSIG genes 
in lipid homeostasis (26). By anchoring a sterol-sensing retainer protein that is able to 
block the access to the nucleus of a number of transcription factors, INSIG proteins have 
been recognized as key regulators of both cholesterol and fatty acid synthesis (18, 19, 
21). No study, however, has shown evidence of their proposed roles in lipid homeostasis 
in humans. Based on the fact that the gene for INSIG1 is located in a QTL region linked 
to plasma TG levels in our MRC-OB cohort, we examined the role of sequence variants 
in the gene in the modulation of plasma TG levels.  
 
Our initial association analysis using eleven tagSNPs revealed four SNPs 
associated with TG levels. Further analysis of additional sequence variants uncovered by 
re-sequencing suggested the promoter SNP rs2721 as the likely causal variant for the 
observed hyperlipidemia. Genotype effect assessment showed that people homozygous 
for the T allele at rs2721 had significantly elevated plasma TG levels. The association 
was replicated in a second independent cohort, detecting a similar effect in individuals 
homozygous for the T allele. These data suggest that rs2721 in INSIG1 may be causally 
associated with TG levels in our linkage region. However, our analysis also suggests that 
this variant accounts for only a portion of the overall linkage (~5%), suggesting that other 
variants and genes in the QTL interval also affect plasma TG levels. Overall, variance at 
rs2721 explains 1.6% of the observed variance in TG levels in our family cohort. This 
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contribution of this polymorphism, however, may be underestimated since the interaction 
with other genes and beyond INSIG2 locus have not been considered in this study.  
 
The SNP rs2721 resides 2,253 bp upstream of the start codon of INSIG1 in the 
putative promoter region. To test the genotype-specific effect on the transcription of 
INSIG1 in humans, expression profiling was conducted in liver tissue, the putative target 
tissue for INSIG1 action on lipid homeostasis in mice. Our analysis revealed that 
individuals homozygous for the T allele had significantly lower INSIG1 expression 
levels, suggesting that reduced expression of INSIG1 increases circulating plasma TG 
levels. While the expression analysis revealed only two individuals homozygous for the T 
allele in our sample set of 73 individuals, the data nonetheless provide suggestive 
evidence for an effect of this promoter variant on gene repression in vivo. Additional 
samples and tissues will need to be investigated to further substantiate this effect of 
rs2721. 
 
To further validate this potential effect of SNP rs2721 on the promoter function of 
INSIG1, we examined the binding of nuclear proteins to the sequence surrounding rs2721 
by electrophoretic mobility shift assay. Separate custom oligonucleotides specific for the 
alleles of rs2721 and comprising the immediate sequence surrounding the SNP location 
were designed. Oligonucleotides specific for the T allele were able to bind nuclear 
proteins extracted from HepG2 cells, in contrast to the G allele (Figure 2). These data 
demonstrate that the T allele of rs2721 shows differential binding of nuclear proteins in 
vitro, further supporting the hypothesis that this sequence variant affects promoter 
 by guest, on Novem
ber 3, 2010
w
w
w
.jlr.org
D
ow
nloaded from
 
function of INSIG1. Analysis of the sequence using TFBIND (http://tfbind.ims.u-
tokyo.ac.jp/) reveals that rs2721 is located in a putative binding site for the transcription 
factor Pre-B-cell leukemia homeobox 1 (PBX1) which is expressed in the liver and a 
wide variety of other tissues. The binding site is altered in the G allele, reducing the 
probability of PBX1 binding more than 6-fold over the T allele. Additional transcription 
factors with differential binding affinity to the two alleles of rs2721 include Forkhead 
transcription factor (FOXL1) and Caudal type homeobox A (CDXA). This differential 
binding affinity may explain the observed EMSA results, and may be related to the 
observed allele-specific expression difference, although none of the transcription factors 
have been reported to modulate plasma triglyceride levels. Nonetheless, PBX1 has been 
reported to affect glucose tolerance and steroidogenesis, and it has been suggested that 
mutations in PBX1 may promote susceptibility to diabetes (44). However, at this point, 
the specific proteins mediating this effect (binding to the T allele, reducing expression of 
INSIG1, and thereby elevating plasma TG levels) remain to be identified. While the 
EMSA results, in conjunction with the expression analysis of the liver biopsy samples, 
suggest a functional mechanism for rs2721, it is clear that EMSA results do not prove 
functional interactions, and additional molecular studies using transfection assays may be 
required to confirm the initial findings. 
 
It has been shown in animal models that double knockout animals for INSIG1 and 
its only homologue INSIG2 have more significant lipid abnormalities when compared to 
knockout animals for either gene individually (26). We therefore explored the putative 
interactive effect of sequence variants in both human INSIG1 and INSIG2 on plasma 
 by guest, on Novem
ber 3, 2010
w
w
w
.jlr.org
D
ow
nloaded from
 
lipids. By focusing on the functional SNP rs2721 of INSIG1, we tested the gene-gene 
interaction with two INSIG2 variants that have shown repeatedly to be associated with 
BMI and lipid abnormalities in obesity studies. Based on our analysis, INSIG1 does 
interact with INSIG2 in relation to lipid homeostasis. The two INSIG2 SNPs have no 
independent effect on plasma TG levels in our cohort. However, rs7566605 significantly 
enhances the effect seen with rs2721 of INSIG1, and their interaction strengthened the 
association with plasma TG levels (Table 3). Specifically, people possessing GG 
genotype at rs7566605 of INSIG2 no longer show a detectable effect of the TT genotype 
of rs2721 in INSIG1 on TG levels. In contrast, individuals with at least one C allele at 
rs7566605 of INSIG2 showed an enhanced effect of the T allele of rs2721 on TG. These 
data suggest that INSIG2 (or at least the G allele of rs7566605) may be able to 
compensate for the effect of rs2721 in INSIG1. While the exact mechanism remains to be 
elucidated, our analysis overall clearly suggests that rs2721 affects plasma TG levels by 
lowering INSIG1 gene expression in the liver. This effect can be reduced or enhanced by 
the different alleles of rs7566605 in INSIG2.  
Clinically, a reduction of 10 mg/dl in plasma TG levels, independently of the 
impact of treatment on LDL-cholesterol levels, resulted in a 1.4% reduction in risk of 
developing coronary heart disease (CHD), in a report by Miller M et al. (45). In our 
study, the elevation in TG levels in individuals with the TT genotype of rs2721 was 
12.8mg/dl and 14.4 mg/dl for families or unrelated individuals, respectively when the 
population was not stratified by genotypes of INSIG2 at rs7566605. This effect is further 
exacerbated by the co-occurrence of the C allele of rs7566605 in INSIG2 and the TT 
allele of rs2721, resulting in a 32.8 mg/dl elevation in TG levels.  
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            Despite the replication of the linkage finding on chromosome 7q36, all genome-
wide association studies (GWAS) to date exploring lipid traits have failed to detect any 
significant association in this genomic interval. Neither INSIG1 nor any other gene in the 
QTL region has been implicated in any of the lipid trait-related GWAS efforts. Given the 
low linkage disequilibrium between rs2721 and any of the adjacent SNPs on common 
GWAS platforms, it is not surprising why the association of rs2721 with plasma TG 
levels detected in our analysis was not uncovered by GWAS. However, the complete lack 
of association evidence for the entire genomic interval, despite repeated linkage evidence, 
needs to be investigated further. This effect has been reported before, and is not specific 
to this QTL region or lipid traits (46).  
The lack of comparable findings in other studies may also be due to differences in 
the recruitment of the study cohorts. In our study design, we excluded individuals with 
hepatic disease, severe coronary artery disease, dramatic weight loss in the preceding 12 
months, or individuals taking lipid-lowering medications. Given the suggested function 
of the INSIG genes, these criteria may themselves be associated with INSIG function, 
thus may have potential influence on the results. Likewise, it remains to be seen whether 
the expression profiles obtained from liver samples collected from bariatric surgery 
patients reflect the levels of INSIG1 expression in the general population.  
 
While INISG1 is not the only gene and rs2721 not the only sequence variant 
responsible for the initially observed linkage on human chromosome 7q36, our analysis, 
for the first time, demonstrates a significant role for this gene in the control and 
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regulation of plasma TG levels, and suggests a functional mechanism by which the causal 
variant rs2721 may exert its effect. Further QTL-wide analyses will be required to 
elucidate the other remaining genetic factors affecting plasma TG levels in our cohort, 
and validate the effect on this important cardiovascular disease risk factor in other patient 
cohorts. 
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Figure Legends 
 
Figure 1. Schematic illustration of the INSIG1 gene region. All SNPs investigated across 
the gene region (154,696,933 bp-154,736,613 bp) are shown relative to the INSIG1 gene, 
depicted by the black line. Translated exons are shown by white boxes, untranslated 
exonic regions are indicated by grey boxes. SNPs used in the initial association analysis 
are highlighted in green, SNPs uncovered by resequencing are shown in black. The 
associated promoter SNP rs2721 is highlighted by the red box. The colored diagram 
depicts the pairwise linkage disequilibrium between SNPs (D’), as calculated for the 
family-based cohort of 1,560 individuals using the program Haploview. 
 
Figure 2. Electrophoretic mobility shift assay of rs2721 using nuclear extract of liver 
HepG2 cells. Oligos of DNA sequences from INSIG1 promoter region centered with 
either allele of rs2721 (T or G) were incubated with total nuclear proteins from cultured 
liver cells. Arrows point at mobility shift of oligonucleotides with the T allele caused by 
differential protein binding. Results are representative of at least two independent 
experiments.  
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Table Legends 
 
Table 1. Summary statistics for the cohorts used in this study, the original 1,560 
individuals of the MRC-OB Family Cohort and 920 unrelated individuals of the 
replication cohort. 
 
Table 2. Summary of SNP association results. All SNPs and their position are listed, 
together with p-values for association with plasma triglyceride levels in the MRC-OB 
family cohort and the replication cohort. SNPs highlighted in green were used in the 
initial association analysis. The results for SNP rs2721 are highlighted by the box. 
 
Table 3. Interaction analysis of rs7566605 in INSIG2 and rs2721 in INSIG1. The C-allele 
of rs7566605 significantly enhances the association of rs2721 with plasma TG levels. 
* = significant difference when compared to GG of rs2721 (p=0.00117) 
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Table 1. 
              
    MRC-OB Family Cohort   Replication Cohort 
              
    Average Range   Average Range 
              
  n 1560     920   
  % female 71     80   
  Age (years) 46 18-90   54 18-89 
  BMI (kg/m2) 31.9 17.1-75.3   32.6 15.9-86.1 
  Triglycerides (mg/dl) 128.0 27-457   135.8 36-424 
  LDL Cholesterol (mg/dl) 106.8 13-245   131.0 33-251 
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Table 2. 
      p-value  p-value  
  SNP position MRC-OB family cohort MAF Replication cohort MAF 
            
  rs6597489 154696933 0.206 0.372    
  rs10901042 154697319 0.184 0.371    
  rs9691590 154701180 0.250 0.162    
  rs9801154 154707375 0.126 0.028    
  rs9801301 154709667 0.516 0.462    
  rs9690040 154716649 0.045 0.372    
  rs9691897 154718254 0.255 0.434    
  SNP1 154718324 0.127 0.018    
  rs2721 154718676 0.002 0.145 0.0008 0.151
  rs1128640 154718751 0.542 0.114    
  rs10271719 154718998 0.284 0.129    
  rs12154226 154719026 0.146 0.425    
  rs12154352 154719048 0.165 0.423    
  rs12154437 154719051 0.153 0.423    
  SNP2 154719102 0.146 0.427    
  SNP3 154719128 0.119 0.422    
  SNP4 154719186 0.111 0.423    
  rs1128636 154719304 0.098 0.42    
  rs9692271 154719881 0.185 0.423    
  SNP5 154720345 0.464 0.078    
  SNP6 154721022 0.464 0.001    
  SNP7 154721030 0.207 0.001    
  SNP8 154721574 0.202 0.133   
  rs9767875 154722339 0.555 0.132    
  rs9768687 154726371 0.148 0.117    
  rs9770068 154730695 0.047 0.363    
  rs9769506 154730788 0.037 0.421    
  rs12381375 154736613 0.151 0.255    
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 Table 3. 
        
  rs7566605 rs2721 triglycerides (mg/dl) 
        
  CC and CG GG 105.6  ± 1.7 
  (n=763) GT 117.9 ± 1.8 
    TT 138.4 ± 1.9* 
        
  GG GG 107.8 ± 1.7 
  (n=768) GT 108.9 ± 1.8 
    TT 98.5 ± 1.6 
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Figure 2. 
 
allele    T      G      T     G     T      G     
biotin    +       +      +      +      -       - 
 NE       +       +       -       -      +      + 
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